https://www.selleckchem.com/pr....oducts/ddr1-in-1.htm
4%, respectively. PLVI measurements ranged from 0.24 to 1.19 with a mean of 0.59 ± 0.17 and a median of 0.603. A total of 51 patients with a median value of 0.603 were defined as low PLVI group, and 52 patients with a median value of ≥0.603 were defined as the high PLVI group. PLVI was significantly low in deceased patients. Age, ASA score and PLVI value were independently associated with a poor overall survival. CONCLUSION There is a significant correlation between sarcopenia and postoperative mortality after vertebral augmentation p